Search the Molecular Cell and Cancer Biology site

About
About

Located at the University of Massachusetts Chan Medical School in Worcester, MA, the Department of Molecular, Cell & Cancer Biology is a collaborative group dedicated to translating fundamental discoveries in biomedical research into novel therapeutic strategies for cancer and other diseases.
Faculty
Faculty

Our faculty make innovative, high-impact discoveries in biomedical research in molecular, cell and cancer biology.
Research
Research

Explore how our bold discoveries are redefining our understanding of how diseases start and can be treated.
Bioinformatics Core
Bioinformatics Core

The MCCB Bioinformatics Core is a unique in-house resource that provides cutting-edge bioinformatics and biostatistics support to researchers in the department.
Education
Education

MCCB is dedicated to fostering innovation and training the next generation of scientists. Learn more about how MCCB equips students and early-career researchers with the skills and knowledge to drive scientific discovery.
- Postdoctoral Training
  
  Postdoctoral Training
  
  Educational Enrichment Activities
  
  Professional Development & Support
  
  MCCB Postdoc Achievements
- Graduate Training
  
  Graduate Programs
  
  Educational Enrichment Activities
  
  Professional Development & Support
  
  Current MCCB Students
  
  MCCB Student Achievements
  
  Michael R. Green, MD, PhD, Award in Graduate Research
  
  MCCB Faculty Awards in Education
Diversity
Diversity

MCCB is committed to promoting an equitable and inclusive environment. Learn more about how we are fostering a positive research culture.
Support Us
Support Us

Learn more about how you can support MCCB’s fundraising initiatives to advance research at UMass Chan.
- Michael R. Green, MD, PhD, Award in Graduate Research
- UMass Chan Cancer Research Team

Additional Resources

Page Menu

Cutting-edge research projects from MCCB faculty awarded UMass Chan BRIDGE Funds

Date Posted: Wednesday, July 03, 2024

Three MCCB faculty are 2024 UMass Chan BRIDGE Fund awardees! The projects were awarded on the basis of their promise for translation to clinical application and commercialization.

Sharon Cantor, PhD: GapScore assay identifies chemo-sensitive cancers

Marcus Ruscetti, PhD: Engineering multi-targeted LNPs for improved delivery and retention of tumor and immune therapies in pancreatic cancer

Scot Wolfe, PhD: CRISPR-mediated selective killing of cancer cells harboring gene amplifications

Read the full story from UMass Chan News.